These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38874442)

  • 41. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prebiotics and Probiotics in Digestive Health.
    Quigley EMM
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):333-344. PubMed ID: 30267869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal microbiota transplantation in HIV: A pilot placebo-controlled study.
    Serrano-Villar S; Talavera-Rodríguez A; Gosalbes MJ; Madrid N; Pérez-Molina JA; Elliott RJ; Navia B; Lanza VF; Vallejo A; Osman M; Dronda F; Budree S; Zamora J; Gutiérrez C; Manzano M; Vivancos MJ; Ron R; Martínez-Sanz J; Herrera S; Ansa U; Moya A; Moreno S
    Nat Commun; 2021 Feb; 12(1):1139. PubMed ID: 33602945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiome a promising target for management of respiratory diseases.
    Trivedi R; Barve K
    Biochem J; 2020 Jul; 477(14):2679-2696. PubMed ID: 32726437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probiotics, prebiotics and amelioration of diseases.
    Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
    J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
    Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
    J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
    Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
    World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microbiome's Universe: Impact on health, disease and cancer treatment.
    Réthi-Nagy Z; Juhász S
    J Biotechnol; 2024 Sep; 392():161-179. PubMed ID: 39009231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects.
    Serrano-Villar S; Vázquez-Castellanos JF; Vallejo A; Latorre A; Sainz T; Ferrando-Martínez S; Rojo D; Martínez-Botas J; Del Romero J; Madrid N; Leal M; Mosele JI; Motilva MJ; Barbas C; Ferrer M; Moya A; Moreno S; Gosalbes MJ; Estrada V
    Mucosal Immunol; 2017 Sep; 10(5):1279-1293. PubMed ID: 28000678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.
    Ceccarelli G; Statzu M; Santinelli L; Pinacchio C; Bitossi C; Cavallari EN; Vullo V; Scagnolari C; d'Ettorre G
    Expert Opin Biol Ther; 2019 Sep; 19(9):949-965. PubMed ID: 31260331
    [No Abstract]   [Full Text] [Related]  

  • 52. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review.
    Baldi S; Mundula T; Nannini G; Amedei A
    World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The human microbiome and gut-liver axis in people living with HIV.
    Duarte MJ; Tien PC; Somsouk M; Price JC
    Curr HIV/AIDS Rep; 2023 Jun; 20(3):170-180. PubMed ID: 37129834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiome-Induced Autoimmunity and Novel Therapeutic Intervention.
    Evrensel A
    Adv Exp Med Biol; 2023; 1411():71-90. PubMed ID: 36949306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.
    Bandera A; De Benedetto I; Bozzi G; Gori A
    Curr Opin HIV AIDS; 2018 Jan; 13(1):73-80. PubMed ID: 29045252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
    Kapoor B; Gulati M; Gupta R; Singla RK
    Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
    Dale HF; Lied GA
    Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overview of the Importance of Biotics in Gut Barrier Integrity.
    Kocot AM; Jarocka-Cyrta E; Drabińska N
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.